Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J Cheskin

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
The Journal of Nutrition|October 5, 2001
The pathogens are speaking: are we listening?L J Cheskin
The American Journal of Managed Care|September 26, 2001
Nonsteroidal anti-inflammatory drugs, cyclooxygenase inhibitors, and the risk of gastrointestinal complicationsL J Cheskin
Gastroenterology|October 29, 2010
Hepatitis as observed in an Army general hospitalJ BANK, L J CHESKIN
The Gastroenterologist|July 11, 1998
Update on obesity treatmentD C Schaefer, L J Cheskin
Journal of the American Geriatrics Society|September 1, 1993
Diverticular disease in the elderlyR C Deckmann, L J Cheskin
The Journal of the American Osteopathic Association|December 1, 1992
Irritable bowel syndromeS A Moscatello, L J Cheskin
Drugs & Aging|January 1, 1995
Diverticular disease. Epidemiology and pharmacological treatmentL J Cheskin, R D Lamport
JAMA|November 22, 2001
msJAMA: Appearance vs health as motivators for weight lossL J Cheskin, L F Donze
Journal of Clinical Psychology|April 1, 1999
Optimism and obesity treatment outcomesK R Fontaine, L J Cheskin
The American Journal of Gastroenterology|May 1, 1991
Endoscopist's nirvana or new heartburn for third-party payers?L J Cheskin, M M Schuster
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
The Journal of Nutrition|October 5, 2001
The pathogens are speaking: are we listening?L J Cheskin
The American Journal of Managed Care|September 26, 2001
Nonsteroidal anti-inflammatory drugs, cyclooxygenase inhibitors, and the risk of gastrointestinal complicationsL J Cheskin
Gastroenterology|October 29, 2010
Hepatitis as observed in an Army general hospitalJ BANK, L J CHESKIN
The Gastroenterologist|July 11, 1998
Update on obesity treatmentD C Schaefer, L J Cheskin
Journal of the American Geriatrics Society|September 1, 1993
Diverticular disease in the elderlyR C Deckmann, L J Cheskin
The Journal of the American Osteopathic Association|December 1, 1992
Irritable bowel syndromeS A Moscatello, L J Cheskin
Drugs & Aging|January 1, 1995
Diverticular disease. Epidemiology and pharmacological treatmentL J Cheskin, R D Lamport
JAMA|November 22, 2001
msJAMA: Appearance vs health as motivators for weight lossL J Cheskin, L F Donze
Journal of Clinical Psychology|April 1, 1999
Optimism and obesity treatment outcomesK R Fontaine, L J Cheskin
The American Journal of Gastroenterology|May 1, 1991
Endoscopist's nirvana or new heartburn for third-party payers?L J Cheskin, M M Schuster
Pageof 7